BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33921783)

  • 1. Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.
    Uruski P; Mikuła-Pietrasik J; Pakuła M; Budkiewicz S; Drzewiecki M; Gaiday AN; Wierzowiecka M; Naumowicz E; Moszyński R; Tykarski A; Książek K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
    Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
    J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.
    Estermann M; Huang YL; Septiadi D; Ritz D; Liang CY; Jacob F; Drasler B; Petri-Fink A; Heinzelmann-Schwarz V; Rothen-Rutishauser B
    PLoS One; 2020; 15(12):e0241500. PubMed ID: 33270665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
    Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
    Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells.
    Pakuła M; Witucka A; Uruski P; Radziemski A; Moszyński R; Szpurek D; Maksin K; Woźniak A; Sajdak S; Tykarski A; Mikuła-Pietrasik J; Książek K
    Sci Rep; 2019 May; 9(1):7587. PubMed ID: 31110245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites.
    Pakuła M; Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Int J Biochem Cell Biol; 2018 May; 98():82-88. PubMed ID: 29550585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
    Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
    J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
    Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
    Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells.
    Wei M; Yang T; Chen X; Wu Y; Deng X; He W; Yang J; Wang Z
    Oncotarget; 2017 Jun; 8(26):42262-42271. PubMed ID: 28178689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources.
    Zhang XY; Pettengell R; Nasiri N; Kalia V; Dalgleish AG; Barton DP
    J Soc Gynecol Investig; 1999; 6(6):333-40. PubMed ID: 10643588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin.
    Ksiazek K; Mikula-Pietrasik J; Korybalska K; Dworacki G; Jörres A; Witowski J
    Am J Pathol; 2009 Apr; 174(4):1230-40. PubMed ID: 19246646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell‑fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer.
    Han Q; Huang B; Huang Z; Cai J; Gong L; Zhang Y; Jiang J; Dong W; Wang Z
    Int J Mol Med; 2019 Dec; 44(6):2245-2255. PubMed ID: 31638162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
    Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
    J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel strategy of ovarian cancer implantation: Pre-invasive growth of fibrin-anchored cells with neovascularization.
    Matsuoka A; Mizumoto Y; Ono M; Kagami K; Obata T; Terakawa J; Maida Y; Nakamura M; Daikoku T; Fujiwara H
    Cancer Sci; 2019 Aug; 110(8):2658-2666. PubMed ID: 31199029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo.
    Mikuła-Pietrasik J; Sosińska P; Kucińska M; Murias M; Maksin K; Malińska A; Ziółkowska A; Piotrowska H; Woźniak A; Książek K
    Cancer Lett; 2014 Dec; 355(2):310-5. PubMed ID: 25301450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraperitoneal invasiveness of ovarian cancer from the cellular and molecular perspective].
    Sosińska P; Mikuła-Pietrasik J; Kuczmarska A; Książek K
    Ginekol Pol; 2015 Oct; 86(10):782-6. PubMed ID: 26677589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.